92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study
Title:
92: [177Lu]Lu-Dota-Tate as First-Line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumours (GEP-NETS): The NETTER-2 Study
Author:
Myrehaug, Sten Singh, Simron Pavel, Marianne Kunz, Pamela de Herder, Wouter Herrmann, Ken D’Amelio Jr, Anthony Santoro, Paola Folitar, Ilya Ferone, Diego